Skip to content

Drug interactions

Diphenoxylate-atropine + Umeclidinium bromide

Severity: Minor

Diphenoxylate-atropine and Umeclidinium bromide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Umeclidinium is an inhaled long-acting antimuscarinic, and atropine is systemically anticholinergic. Combining them may add to systemic anticholinergic effects such as dry mouth, constipation, urinary retention and increased heart rate, although inhaled systemic exposure is low.

What this interaction means in plain words

Diphenoxylate-atropine and Umeclidinium bromide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Additive antimuscarinic receptor blockade.

What to do

Monitor for anticholinergic symptoms, especially in older patients or those with glaucoma or urinary obstruction. Review the need for diphenoxylate-atropine if symptoms develop.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Diphenoxylate-atropine and Umeclidinium bromide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Diphenoxylate-atropine with Umeclidinium bromide?

MediHelp rates the interaction as minor. Diphenoxylate-atropine and Umeclidinium bromide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Umeclidinium is an inhaled long-acting antimuscarinic, and atropine is systemically anticholinergic. Combining them may add to systemic anticholinergic effects such as dry mouth, constipation, urinary retention and increased heart rate, although inhaled systemic exposure is low.

How serious is the interaction between Diphenoxylate-atropine and Umeclidinium bromide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for anticholinergic symptoms, especially in older patients or those with glaucoma or urinary obstruction. Review the need for diphenoxylate-atropine if symptoms develop.

What other medicines interact with Diphenoxylate-atropine?

MediHelp also lists interactions of Diphenoxylate-atropine with, for example, Isocarboxazid, Phenelzine, Tranylcypromine. The full list is on the Diphenoxylate-atropine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in